BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 10473110)

  • 1. Fenretinide activates caspases and induces apoptosis in gliomas.
    Puduvalli VK; Saito Y; Xu R; Kouraklis GP; Levin VA; Kyritsis AP
    Clin Cancer Res; 1999 Aug; 5(8):2230-5. PubMed ID: 10473110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL).
    Faderl S; Lotan R; Kantarjian HM; Harris D; Van Q; Estrov Z
    Leuk Res; 2003 Mar; 27(3):259-66. PubMed ID: 12537979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.
    Scher RL; Saito W; Dodge RK; Richtsmeier WJ; Fine RL
    Otolaryngol Head Neck Surg; 1998 Apr; 118(4):464-71. PubMed ID: 9560096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer effects of fenretinide in human medulloblastoma.
    Damodar Reddy C; Guttapalli A; Adamson PC; Vemuri MC; O'Rourke D; Sutton LN; Phillips PC
    Cancer Lett; 2006 Jan; 231(2):262-9. PubMed ID: 16399227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
    Ohlmann CH; Jung C; Jaques G
    Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent effect of 5-HPBR, a butanoate derivative of 4-HPR, on cell growth and apoptosis in cancer cells.
    Han HS; Kwon YJ; Park SH; Kim EJ; Rho YS; Sin HS; Um SJ
    Int J Cancer; 2004 Mar; 109(1):58-64. PubMed ID: 14735468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.
    Shan D; Gopal AK; Press OW
    Clin Cancer Res; 2001 Aug; 7(8):2490-5. PubMed ID: 11489831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide in glioma cells.
    Saitoh Y; Goto T; Puduvalli VK; Murakami M; Kochi M; Levin VA; Kyritsis AP; Ushio Y
    Int J Oncol; 1999 Sep; 15(3):499-504. PubMed ID: 10427131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of N-(4-hydroxyphenyl)retinamide-induced apoptosis in breast cancer cells by galectin-3.
    Choi JH; Chun KH; Raz A; Lotan R
    Cancer Biol Ther; 2004 May; 3(5):447-52. PubMed ID: 15326375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.
    Kalemkerian GP; Slusher R; Ramalingam S; Gadgeel S; Mabry M
    J Natl Cancer Inst; 1995 Nov; 87(22):1674-80. PubMed ID: 7473815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
    Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
    Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines.
    Kouhara J; Yoshida T; Nakata S; Horinaka M; Wakada M; Ueda Y; Yamagishi H; Sakai T
    Int J Oncol; 2007 Mar; 30(3):679-87. PubMed ID: 17273769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression.
    Supino R; Crosti M; Clerici M; Warlters A; Cleris L; Zunino F; Formelli F
    Int J Cancer; 1996 Feb; 65(4):491-7. PubMed ID: 8621233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis in primary meningioma cultures by fenretinide.
    Puduvalli VK; Li JT; Chen L; McCutcheon IE
    Cancer Res; 2005 Feb; 65(4):1547-53. PubMed ID: 15735044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
    Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U
    Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy-induced death of MCF-7 human breast cancer cells: a role for caspase-3 in the late steps of apoptosis but not for the critical lethal event.
    Xue LY; Chiu SM; Oleinick NL
    Exp Cell Res; 2001 Feb; 263(1):145-55. PubMed ID: 11161713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines.
    Zou CP; Kurie JM; Lotan D; Zou CC; Hong WK; Lotan R
    Clin Cancer Res; 1998 May; 4(5):1345-55. PubMed ID: 9607596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma.
    Lovat PE; Ranalli M; Annichiarrico-Petruzzelli M; Bernassola F; Piacentini M; Malcolm AJ; Pearson AD; Melino G; Redfern CP
    Exp Cell Res; 2000 Oct; 260(1):50-60. PubMed ID: 11010810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide.
    Di Vinci A; Geido E; Infusini E; Giaretti W
    Int J Cancer; 1994 Nov; 59(3):422-6. PubMed ID: 7927952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.